March 13, 2019
Alvotech first biosimilar product, version of Humira, enrolls first patient in study
Alvotech has enrolled the first patient to test its Humira biosimilar candidate in Alvopad PS, in a Phase III clinical study (ALVOPAD PS), for adult patients with moderate to severe chronic plaque psoriasis.